Healthcare >> CEO Interviews >> January 13, 2000
ELIZABETH H. DAVILA joined VISX, Inc. on May 3, 1995 as Executive Vice
President and Chief Operating Officer, became a Director in December of
1995, and was elevated to the position of President on February 26,
1999. From 1977 to 1994, Ms. D'vila held senior management positions
with Syntex Corporation, Palo Alto, CA, which included Vice President of
Quality and Reengineering reporting to the President and COO and was
responsible for organizing and directing the redesign of the
corporation. In prior positions at Syntex, Ms. D'vila served as Vice
President and Director of their Drug Development Optimization Program,
Vice President of U.S. Marketing and Sales for the Syva Company Medical
Diagnostics Division and Vice President of Marketing and Sales of the
Syntex Ophthalmics Division. Ms. D'vila has a Masters Degree in
Chemistry from the University of Notre Dame and an MBA from Stanford
University. She is also a director on the board of VidaMed. Profile
company just to set the stage for the readers?
Ms. Davila: VISX was founded in 1986. We are the world leader in
